Company intelligence / Profile preview

Genomma Lab

Mexico City, Ciudad de México, Mexicogenommalab.com ↗
Ownership
Private
Employees
~1665
Development stage
Other
01

Overview

Genomma Lab operates primarily in the consumer health and OTC pharmaceutical sectors; its products—including several market-leading brands for pain relief, GI, dermal, and beauty care—are commercially available across Latin America, the US, and other markets, with no clinical pipeline typical of a biotech or pharma development-stage company.

Therapeutic areas
RheumatologyInfectious DiseasesGastroenterologyDermatologyCardiovascularNeurology
Modalities
Small moleculetopicalbeverage
Industry
Biotech
02

Drug pipeline

3 assets

Suerox

Unknown

2 more assets in the full pipeline.

03

Partnerships

IFC (International Finance Corporation) multi-currency loan partnership

Beyond the preview

Go deeper on Genomma Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomma Lab.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call